...BRCA2 mutation carriers, BRCA1 mutation carriers, and non-carriers, respectively, p value = 0.03). Women with BRCA2 muta...
...BRCA2-mutated tumors were significantly correlated to specific subtypes. In this chapter, we will review the current sta...
...BRCA2, declines in single mouse and human oocytes. In Brca1-deficient mice, reproductive capacity was impaired, primordi...
The identification of the two most prevalent susceptibility genes in breast cancer, BRCA1 and BRCA2, was the beginning o...
...BRCA2 and 77 non-BRCA mutation-related cases. HIF-1α expression was detected in 63% of BRCA1 and 62% of BRCA2 as compare...
To analyze the baseline clinicopathologic characteristics of prostate tumors with germline BRCA1 and BRCA2 (BRCA1/2) mut...
...BRCA2 that impair homologous recombination. However, since many tumors, including prostate cancer (PCa) rarely have on s...
...BRCA2, and TP53, more than a dozen breast cancer susceptibility genes have been identified. Recognizing affected individ...
...BRCA2 mutations, as well as Klinefelter syndrome. Several retrospective trials of surgical therapy in stage IV breast ca...
...BRCA2, the risk of developing breast or ovarian cancer is significantly increased. In recent years there has been increa...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2026.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
